Understanding AML Induction and Consolidation Therapy
Understanding AML Induction and Consolidation Therapy
Dr. Hetty Carraway, an AML specialist at Cleveland Clinic, provides an explanation of the role of induction and consolidation therapy in AML patients. Dr. Hetty Carraway is Director of the Leukemia Program at Cleveland Clinic. [More]
485 views
no comments
HPV Advances – Induction Chemotherapy
HPV Advances – Induction Chemotherapy
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell Yarbrough discusses using induction to guide radiation. For more, please visit http://cancerGRACE.org/. To join the [More]
452 views
no comments
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
502 views
no comments
Asvide: Completion pneumonectomy: right lower lobectomy after induction chemotherapy…
Asvide: Completion pneumonectomy: right lower lobectomy after induction chemotherapy…
Completion pneumonectomy: right lower lobectomy after induction chemotherapy (previous bilobectomy) For more detail: http://www.asvide.com/articles/57
451 views
no comments
Is high dose chemotherapy still as important in AML?
Is high dose chemotherapy still as important in AML?
Jeffrey Lancet, MD, of H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses the relevance of high-dose chemotherapy in the treatment of acute myeloid leukemia (AML). This interview was recorded via an online [More]
540 views
no comments
Introduction: Neoadjuvant Chemotherapy
Introduction: Neoadjuvant Chemotherapy
In this segment, Dean F. Bajorin, MD, comments on treatment approaches for muscle-invasive bladder cancer.
558 views
no comments
Single versus double induction with 7+3 for newly diagnosed AML
Single versus double induction with 7+3 for newly diagnosed AML
Christoph Röllig, MD, MSc, Dresden University of Technology, Dresden, Germany, outlines the results of the randomized-controlled SAL-DaunoDouble trial (NCT02140242), comparing remission and survival in newly diagnosed acute myeloid leukemia (AML) patients treated after single versus [More]
418 views
no comments
De-escalating chemo-radiotherapy in locally advanced HPV+ oropharynx cancer
De-escalating chemo-radiotherapy in locally advanced HPV+ oropharynx cancer
Marshall R. Posner, MD, The Tisch Cancer Institute, New York, NY, describes an analysis of patients with locally advanced human papillomavirus (HPV)-positive oropharynx cancer (OPC) from two different trials (NCT02945631, NCT01706939) who received induction chemotherapy [More]
673 views
no comments
Neoadjuvant Chemotherapy for Gastric Cancer Patients
Neoadjuvant Chemotherapy for Gastric Cancer Patients
Carlo M. Contreras, MD, FACS, discusses the benefits of several neoadjuvant treatment options for patients with gastric cancer.
633 views
no comments
Debate: Treatment for Resectable Pancreatic Cancer? – Neo-Adjuvant Chemotherapy
Debate: Treatment for Resectable Pancreatic Cancer? – Neo-Adjuvant Chemotherapy
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the ‘2019 ESMO World Congress on Gastrointestinal Cancer’, Dr. Thomas Seufferlein argues in favor of the use of neo-adjuvant chemotherapy for the treatment of resectable [More]
514 views
9 comments